Literature DB >> 9731234

Fine structural and functional consequences of deglycosylation of the platelet adhesion receptor GPIb-IX (CD 42b).

K Moshfegh1, S Lengweiler, M Häner, U Aebi, B Steiner, J H Beer.   

Abstract

To investigate the role of the glycosylation of the platelet receptor glycoprotein Ib (GPIb, CD 42b), platelets and purified GPIb were deglycosylated by neuraminidase, O- and N-glycosidases. N-deglycosylation and neuraminic-acid cleavage had little effect on ristocetin and botrocetin-induced platelet agglutination. However, O-deglycosylation reduced the response by approximately 50%, and total deglycosylation (the combination of all three glycosidases) fully abolished the response to ristocetin. Interestingly, binding of von Willebrand Factor (vWF) to purified GPIb in the presence of ristocetin and botrocetin in a standardized microtiter plate assay was not altered by partial or even by total deglycosylation. Electron microscopy indicated that the normally stretched approximately 50 nm long molecule was approximately 32 nm after N-deglycosylation, approximately 20 nm after O-deglycosylation, and reduced in a approximately 15 nm long collapse by total deglycosylation. These results suggest that deglycosylation has major structural impacts on GPIb, strongly impairing platelet-vWF interactions; however, vWF binding to isolated GPIb remains unaffected.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731234     DOI: 10.1006/bbrc.1998.9125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications.

Authors:  C Van Geet; J Jaeken; K Freson; T Lenaerts; J Arnout; J Vermylen; M F Hoylaerts
Journal:  J Inherit Metab Dis       Date:  2001-08       Impact factor: 4.982

2.  Platelet biogenesis and functions require correct protein O-glycosylation.

Authors:  Yingchun Wang; Shawn M Jobe; Xiaokun Ding; Hyojung Choo; David R Archer; Rongjuan Mi; Tongzhong Ju; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

3.  Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP.

Authors:  Bojing Shao; Christopher Hoover; Huiping Shi; Yuji Kondo; Robert H Lee; Junmei Chen; Xindi Shan; Jianhua Song; J Michael McDaniel; Meixiang Zhou; Samuel McGee; Karen Vanhoorelbeke; Wolfgang Bergmeier; José A López; James N George; Lijun Xia
Journal:  Blood       Date:  2022-04-21       Impact factor: 22.113

4.  Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance.

Authors:  Simona Stivala; Sara Gobbato; Laura Infanti; Martin F Reiner; Nicole Bonetti; Sara C Meyer; Giovanni G Camici; Thomas F Lüscher; Andreas Buser; Jürg H Beer
Journal:  Haematologica       Date:  2017-07-20       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.